3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
54
Carcinoma, Non-Small-Cell Lung
22
Neoplasms
17
Neoplasm Metastasis
16
Breast Neoplasms
16
Triple Negative Breast Neoplasms
10
Colorectal Neoplasms
9
Stomach Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Ovarian Neoplasms
6
Melanoma
5
Carcinoma, Pancreatic Ductal
5
Adenocarcinoma
5
Small Cell Lung Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Hepatocellular
4
Rectal Neoplasms
3
Peritoneal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Lymphoma, Non-Hodgkin
3
Lung Neoplasms
3
Hodgkin Disease
3
Fallopian Tube Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Solid Tumor
2
Sarcoma
2
Prostatic Neoplasms
2
Pancreatic Ductal Adenocarcinoma
2
Nasopharyngeal Carcinoma
2
Interventions
Gemcitabine
2
Taxes
1
Radiotherapy, Conformal
1
Metformin
1
Ethiodized Oil
1
Albumin-Bound Paclitaxel
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Pancreatic Adenocarcinoma
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT02174887
2017-03-28
MOAnab1
Institut Paoli-Calmettes
Phase 1
Completed
19 enrolled